Scientific Program – FETOMATERNAL MEDICINE

Friday, November 28 & Saturday, November 29, 2025

Friday, November 28

08:30-09:00 GOOD MORNING ROME PLENARY LECTURE Live streamed from HALL A
Capsule A decade ago, a pioneering procedure was successfully launched
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
08:30-08:25 Pioneering uterus transplantation: Reflections on breakthroughs and deliveries
Mats Brännström, Sweden
08:25-08:30 Discussion

 

09:00-10:00 PREGNANCY IMPACT IS MORE THAN 9 MONTHS HALL D
Chairpersons Gerard Visser, Netherlands
09:00-09:20

Developmental origins of health and disease (DOHaD) hypothesis: Current state and implications for ART

09:20-09:40

The health of children conceived by ART: ‘The chicken or the egg?
Anja Pinborg, Denmark

09:40-10:00

Can we blame pregnancy complications in the development of Autism Spectrum Disorder (ASD)?
Eyal Sheiner, Israel

 

10:00-10:30 Coffee break, visit the exhibition, and e-poster viewing

 

10:30-12:00 PRETERM DELIVERY HALL D
Chairpersons Giuseppe Rizzo, Italy
10:30-10:50

10:30
10:35
10:40

Debate: The role of routine cervical length screening in low-risk pregnancies – should universal screening be standard, or should it be reserved for high-risk groups?

To all: Yariv Yogev, Israel
Only for HRP: 
Discussion

10:40-11:00

10:40
10:45
10:50

Debate: Mg sulfate administration when preterm delivery is expected in less than 2 hours

Yes: Liran Hiersch, Israel
No: Emmanuel Attali, Israel
Discussion

11:00-11:20

Antenatal corticosteroids – what is the optimal timing?

11:20-11:40

Evidence based data – ultrasound based cerclage – to whom?

11:40-12:00

11:40
11:45
11:50

Debate: Should we provide corticosteroids for late preterm (35-37 weeks)?

Yes: Howard Berger, Canada
No: Gerard Visser, Netherlands
Discussion

 

12:00-12:05 Short break

 

12:05-13:05 INDUSTRY SUPPORTED SESSION HALL A and B

 

13:05-14:00 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:00-15:00 INDUSTRY SUPPORTED SESSION HALL A and B

 

15:00-15:05 Short break

 

15:05-16:35 LABOR AND DELIVERY HALL D
Chairpersons Giuseppe Rizzo, Italy
Eyal Sheiner, Israel
15:05-15:25 New aspects of labor monitoring including US in labor
Giuseppe Rizzo, Italy
15:35-15:55

15:35
15:40
15:45

Debate: Should we provide antibiotics after operative vaginal delivery?

Yes: Emmanuel Attali, Israel
No: Amir Aviram, Canada
Discussion

15:55-16:15

Introduction of the US machine in the labor ward: Pros and cons

16:15-16:35

16:15
16:20
16:25

Debate: Should women with previous 3rd degree tear undergo vaginal delivery

Yes:
No: Eyal Sheiner, Israel
Discussion

 

16:35-17:00 Coffee break, visit the exhibition, and e-poster viewing

 

17:00-18:30 OBESITY, DIABESITY HALL D
Chairpersons Yariv Yogev, Israel
Gerard Visser Netherlands
17:00-17:20

17:00
17:05
17:10

Debate: Should we counsel overweight/obese patients to lose weight during pregnancy?

Yes: Gerard Visser Netherlands
No: Yariv Yogev, Israel
Discussion

17:20-17:50

17:20
17:25
17:30

Debate: Should we screen and treat GDM prior to 24 weeks of gestation?

Yes: Gerard Visser Netherlands
No:
Discussion

17:50-18:10

Myo Inositol preventing and treating GDM
Fabio Facchinetti, Italy

18:10-18:30

Discussion

Saturday, November 29

08:30-10:00 GOOD MORNING ROME PLENARY LECTURE Live streamed from HALL A
Capsule
Chairpersons

Bart Fauser, Netherlands
Jacques Donnez, Belgium

08:30-08:55

Endometriosis before and during pregnancy
Paolo Vercellini, Italy

08:55-09:00 Discussion
09:00-10:30 ADVANCED MATERNAL AGE HALL D
Chairpersons Fabio Facchinetti, Italy
09:00-09:20

When you are too old to rock the cradle? Is there a difference between singleton and twins?
Yariv Yogev, Israel

09:20-09:40

09:20
09:25
09:30

Debate: Should all women over the age of 40 undergo CS?

Yes: Amir Aviram, Canada
No:
Discussion

09:40-10:00

09:40
09:45
09:50

Debate: Should we induce all labor in AMA?

Yes:
No: Fabio Facchinetti, Italy
Discussion

10:00-10:20

Long term health of women and neonates after delivery after the age of 40
Eyal Sheiner, Israel

10:20-10:30 Discussion

 

10:30-11:00 Coffee break, visit the exhibition, and e-poster viewing

 

11:00-12:30 GENETICS AND PRENATAL DIAGNOSIS HALL D
Chairpersons Wolfgang Holzgreve, Germany
11:00-11:20 Non invasive prenatal testing- is it a good option for women after Assisted Reproduction. and for which indications?
Wolfgang Holzgreve, Germany
11:20-11:40

In utero gene therapy – a new horizon?

11:40-12:00

11:40
11:45
11:50

Debate: Should we perform array-based comparative genomic hybridization and whole exome sequencing for all

Yes: Amir Aviram, Canada
No: Adi Reches, Israel
Discussion

12:00-12:20

What is the value of genetic testing in small babies

12:20-12:30

Discussion

 

12:30-13:30 Lunch break, visit the exhibition, and e-poster viewing

 

13:30-15:00 MULTIPLE PREGNANCY: THE MONOCHORIONIC TWIN CHALLENGE HALL D
Chairpersons

13:30-13:45

New aspects in the diagnosis and management of MC twins

13:45-14:00

Fetal growth restriction and significance of size discordance in twins

14:00-14:20

14:00
14:05
14:10

Debate: IUGR

Yes: Gerard Visser, Netherlands
No:
Discussion

14:20-14:40

Controversies in preterm birth in twins

14:40-15:00

14:40
14:45
14:50

Debate: Fetal reduction for all twins? 

Yes: Yariv Yogev, Israel
No: Eyal Sheiner, Israel
Discussion

 

15:00-16:30 ULTRASOUND AND DOPPLER IN NORMAL PREGNANCY HALL D
Chairpersons

15:00-15:20

15:00
15:05
15:10

Debate: First-trimester vs. second-trimester anatomy scan: Should we be pushing for earlier detection? Is a detailed first-trimester scan at 11-13 weeks sufficient, or do we still need a second-trimester scan?

Yes:
No: Valentina Tsibizova, Italy
Discussion

15:20-15:40

15:20
15:25
15:30

Debate: The role of Middle Cerebral Artery (MCA) Doppler in low-risk pregnancies – Should MCA Doppler be incorporated into routine fetal surveillance?

Yes:
No:
Discussion

15:40-16:00

15:40
15:45
15:50

Debate: Third anatomy scan to all?

Yes:
No:
Discussion

16:00-16:20

16:00
16:05
16:10

Debate: Should we abandon the Biophysical Profile (BPP) in favor of Doppler-based surveillance? Is BPP still useful, or should we rely primarily on Doppler?

Yes:
No:
Discussion

16:20-16:30

Discussion

 

Skip to content